Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients.
Brassard M, Borget I, Edet-Sanson A, Giraudet AL, Mundler O, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Toubert ME, Torlontano M, Benhamou E, Schlumberger M; THYRDIAG Working Group. Brassard M, et al. Among authors: bonichon f. J Clin Endocrinol Metab. 2011 May;96(5):1352-9. doi: 10.1210/jc.2010-2708. Epub 2011 Mar 9. J Clin Endocrinol Metab. 2011. PMID: 21389143
Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients.
Schlumberger M, Hitzel A, Toubert ME, Corone C, Troalen F, Schlageter MH, Claustrat F, Koscielny S, Taieb D, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Torlontano M, Tenenbaum F, Bardet S, Bussière F, Girard JJ, Morel O, Schneegans O, Schlienger JL, Prost A, So D, Archambeaud F, Ricard M, Benhamou E. Schlumberger M, et al. Among authors: bonichon f. J Clin Endocrinol Metab. 2007 Jul;92(7):2487-95. doi: 10.1210/jc.2006-0723. Epub 2007 Apr 10. J Clin Endocrinol Metab. 2007. PMID: 17426102 Clinical Trial.
Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
Schlumberger M, Catargi B, Borget I, Deandreis D, Zerdoud S, Bridji B, Bardet S, Leenhardt L, Bastie D, Schvartz C, Vera P, Morel O, Benisvy D, Bournaud C, Bonichon F, Dejax C, Toubert ME, Leboulleux S, Ricard M, Benhamou E; Tumeurs de la Thyroïde Refractaires Network for the Essai Stimulation Ablation Equivalence Trial. Schlumberger M, et al. Among authors: bonichon f. N Engl J Med. 2012 May 3;366(18):1663-73. doi: 10.1056/NEJMoa1108586. N Engl J Med. 2012. PMID: 22551127 Free article. Clinical Trial.
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.
Massicotte MH, Brassard M, Claude-Desroches M, Borget I, Bonichon F, Giraudet AL, Do Cao C, Chougnet CN, Leboulleux S, Baudin E, Schlumberger M, de la Fouchardière C. Massicotte MH, et al. Among authors: bonichon f. Eur J Endocrinol. 2014 Mar 8;170(4):575-82. doi: 10.1530/EJE-13-0825. Print 2014 Apr. Eur J Endocrinol. 2014. PMID: 24424318
Is thyroid cancer recurrence risk increased after transplantation?
Tisset H, Kamar N, Faugeron I, Roy P, Pouteil-Noble C, Klein M, Mourad G, Drui D, Do Cao C, Leenhardt L, Allix I, Bonichon F, Morelon E, Leboulleux S, Kelly A, Niccoli P, Toubert ME, Frimat L, Vantyghem MC, Bournaud C, Schlumberger M, Borson-Chazot F; TUTHYREF network. Tisset H, et al. Among authors: bonichon f. J Clin Endocrinol Metab. 2013 Oct;98(10):3981-8. doi: 10.1210/jc.2013-1357. Epub 2013 Jul 24. J Clin Endocrinol Metab. 2013. PMID: 23884779
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial.
Borget I, Bonastre J, Catargi B, Déandréis D, Zerdoud S, Rusu D, Bardet S, Leenhardt L, Bastie D, Schvartz C, Vera P, Morel O, Benisvy D, Bournaud C, Bonichon F, Kelly A, Toubert ME, Leboulleux S, Journeau F, Benhamou E, Schlumberger M. Borget I, et al. Among authors: bonichon f. J Clin Oncol. 2015 Sep 10;33(26):2885-92. doi: 10.1200/JCO.2015.61.6722. Epub 2015 Aug 3. J Clin Oncol. 2015. PMID: 26240230 Clinical Trial.
Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort.
Chougnet CN, Borget I, Leboulleux S, de la Fouchardiere C, Bonichon F, Criniere L, Niccoli P, Bardet S, Schneegans O, Zanetta S, Schvartz C, Drui D, Chauffert B, Rohmer V, Schlumberger M. Chougnet CN, et al. Among authors: bonichon f. Thyroid. 2015 Apr;25(4):386-91. doi: 10.1089/thy.2014.0361. Epub 2015 Feb 18. Thyroid. 2015. PMID: 25627619
Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.
Leboulleux S, Bastholt L, Krause T, de la Fouchardiere C, Tennvall J, Awada A, Gómez JM, Bonichon F, Leenhardt L, Soufflet C, Licour M, Schlumberger MJ. Leboulleux S, et al. Among authors: bonichon f. Lancet Oncol. 2012 Sep;13(9):897-905. doi: 10.1016/S1470-2045(12)70335-2. Epub 2012 Aug 14. Lancet Oncol. 2012. PMID: 22898678 Clinical Trial.
Percutaneous thermal ablation of lung metastases from thyroid carcinomas. A retrospective multicenter study of 107 nodules. On behalf of the TUTHYREF network.
Bonichon F, de Baere T, Berdelou A, Leboulleux S, Giraudet AL, Cuinet M, Drui D, Liberge R, Kelly A, Tenenbaum F, Legmann P, Do Cao C, Leenhardt L, Toubeau M, Godbert Y, Palussière J. Bonichon F, et al. Endocrine. 2021 Jun;72(3):798-808. doi: 10.1007/s12020-020-02580-2. Epub 2021 Mar 26. Endocrine. 2021. PMID: 33770383
132 results